| 1 |
33599403 | Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population. | 2021 Mar |
1 |
| 2 |
31772310 | Ketamine in seizure management and future pharmacogenomic considerations. | 2020 Jun |
1 |
| 3 |
30589555 | Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches. | 2019 Feb 4 |
3 |
| 4 |
30906561 | Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes. | 2019 Apr |
1 |
| 5 |
28737446 | Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims. | 2018 Jul |
2 |
| 6 |
29621538 | Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression. | 2018 Jun |
1 |
| 7 |
30085944 | Stereoselective Ketamine Metabolism by Genetic Variants of Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase. | 2018 Oct |
9 |
| 8 |
28252572 | Pharmacogenetics of Ketamine-Induced Emergence Phenomena: A Pilot Study. | 2017 Mar/Apr |
1 |
| 9 |
28858450 | Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions. | 2017 Jul |
2 |
| 10 |
27362518 | Pharmacogenetics of Anesthesia: An Integrative Review. | 2016 Jul-Aug |
2 |
| 11 |
27709010 | Insights into CYP2B6-mediated drug-drug interactions. | 2016 Sep |
1 |
| 12 |
27763886 | CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine! | 2016 Dec |
2 |
| 13 |
27763887 | Role of Cytochrome P4502B6 Polymorphisms in Ketamine Metabolism and Clearance. | 2016 Dec |
6 |
| 14 |
25702819 | CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects. | 2015 Aug |
12 |
| 15 |
23467454 | Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. | 2013 |
1 |
| 16 |
23550066 | The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitro. | 2013 Jun |
8 |
| 17 |
21508826 | Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration. | 2011 Jun |
1 |
| 18 |
21716267 | Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine. | 2011 Aug |
1 |
| 19 |
22023129 | Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans. | 2011 Nov |
2 |
| 20 |
20609441 | Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro. | 2010 Dec 17 |
1 |
| 21 |
19442086 | Polymorphic drug metabolism in anaesthesia. | 2009 Mar |
1 |
| 22 |
19702527 | Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. | 2009 Sep |
1 |
| 23 |
18781911 | CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. | 2008 Sep |
1 |
| 24 |
17073575 | The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. | 2006 Oct |
1 |
| 25 |
12065445 | Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. | 2002 Jul |
3 |
| 26 |
11353758 | Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes. | 2001 Jun |
2 |